Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002 | NEJM
Efficacy I PLUVICTO
Simplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies
Durable Response Rate
Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysis | Blood Cancer Journal
Efficacy - Overall Response Rate | Aliqopa US HCP
ORR - "Overall Response Rate" by AcronymsAndSlang.com
Durable Response Rate
Overall Response Rate (ORR) as Function of Baseline C-reactive Protein... | Download Scientific Diagram
Efficacy data | BENDEKA® (bendamustine HCl) injection
Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma | Semantic Scholar
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study | SpringerLink
Response Rates for Waldenström Macroglobulinemia Improve With Use of New First-Line, Better-Tolerated Treatments - U.S. Medicine
Forest plot of the comparison of overall response rate (ORR).